Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
mRNA COVID-19 Vaccination Does Not Exacerbate Symptoms or Trigger Neural Antibody Responses in Multiple Sclerosis.
Blanco Y, Escudero D, Lleixà C, Llufriu S, Egri N, García RR, Alba M, Aguilar E, Artola M, Aldea Novo M, Alvarez S, Caballero E, Cabrera-Maqueda JM, Fonseca E, Guasp M, Hernando A, Martinez-Hernandez E, Olivé-Cirera G, Lopez-Contreras J, Martín-Aguilar L, Martinez-Martinez L, Rombauts A, Rodés M, Sabater L, Sepulveda M, Solana E, Tejada-Illa C, Vidal-Fernández N, Vilella A, Fortuny C, Armangué T, Dalmau JO, Querol L, Saiz A. Blanco Y, et al. Among authors: cabrera maqueda jm. Neurol Neuroimmunol Neuroinflamm. 2023 Sep 7;10(6):e200163. doi: 10.1212/NXI.0000000000200163. Print 2023 Nov. Neurol Neuroimmunol Neuroinflamm. 2023. PMID: 37679040 Free PMC article.
Diffusion tensor imaging metrics associated with future disability in multiple sclerosis.
Lopez-Soley E, Martinez-Heras E, Solana E, Solanes A, Radua J, Vivo F, Prados F, Sepulveda M, Cabrera-Maqueda JM, Fonseca E, Blanco Y, Alba-Arbalat S, Martinez-Lapiscina EH, Villoslada P, Saiz A, Llufriu S. Lopez-Soley E, et al. Among authors: cabrera maqueda jm. Sci Rep. 2023 Mar 2;13(1):3565. doi: 10.1038/s41598-023-30502-5. Sci Rep. 2023. PMID: 36864113 Free PMC article.
Neurological adverse events related to immune-checkpoint inhibitors in Spain: a retrospective cohort study.
Fonseca E, Cabrera-Maqueda JM, Ruiz-García R, Naranjo L, Diaz-Pedroche C, Velasco R, Macias-Gómez A, Milisenda JC, Muñoz-Farjas E, Pascual-Goñi E, Gállego Perez-Larraya J, Saiz A, Dalmau J, Blanco Y, Graus F, Martinez-Hernandez E; Neuro-ICI-Spain study group. Fonseca E, et al. Among authors: cabrera maqueda jm. Lancet Neurol. 2023 Dec;22(12):1150-1159. doi: 10.1016/S1474-4422(23)00335-6. Lancet Neurol. 2023. PMID: 37977714 Review.
Association of Serum Neurofilament Light Chain Levels at Disease Onset With Disability Worsening in Patients With a First Demyelinating Multiple Sclerosis Event Not Treated With High-Efficacy Drugs.
Monreal E, Fernández-Velasco JI, García-Sánchez MI, Sainz de la Maza S, Llufriu S, Álvarez-Lafuente R, Casanova B, Comabella M, Ramió-Torrentà L, Martínez-Rodríguez JE, Brieva L, Saiz A, Eichau S, Cabrera-Maqueda JM, Villarrubia N, Espiño M, Pérez-Miralles F, Montalbán X, Tintoré M, Quiroga-Varela A, Domínguez-Mozo MI, Rodríguez-Jorge F, Chico-García JL, Lourido D, Álvarez-Cermeño JC, Masjuan J, Costa-Frossard L, Villar LM. Monreal E, et al. Among authors: cabrera maqueda jm. JAMA Neurol. 2023 Apr 1;80(4):397-403. doi: 10.1001/jamaneurol.2023.0010. JAMA Neurol. 2023. PMID: 36848127 Free PMC article.
Perception of Medical Professionalism among Medical Residents in Spain.
García-Estañ J, Cabrera-Maqueda JM, González-Lozano E, Fernández-Pardo J, Atucha NM. García-Estañ J, et al. Among authors: cabrera maqueda jm. Healthcare (Basel). 2021 Nov 18;9(11):1580. doi: 10.3390/healthcare9111580. Healthcare (Basel). 2021. PMID: 34828626 Free PMC article.
Axonal Injuries Cast Long Shadows: Long Term Glial Activation in Injured and Contralateral Retinas after Unilateral Axotomy.
González-Riquelme MJ, Galindo-Romero C, Lucas-Ruiz F, Martínez-Carmona M, Rodríguez-Ramírez KT, Cabrera-Maqueda JM, Norte-Muñoz M, Vidal-Sanz M, Agudo-Barriuso M. González-Riquelme MJ, et al. Among authors: cabrera maqueda jm. Int J Mol Sci. 2021 Aug 7;22(16):8517. doi: 10.3390/ijms22168517. Int J Mol Sci. 2021. PMID: 34445225 Free PMC article.
Prevention of rebound effect after natalizumab withdrawal in multiple sclerosis. Study of two high-dose methylprednisolone schedules.
Fuentes-Rumí L, Hernández-Clares R, Carreón-Guarnizo E, Valero-López G, Iniesta-Martinez F, Cabrera-Maqueda JM, León-Hernández A, Zamarro-Parra J, Morales-Ortiz A, Meca-Lallana JE. Fuentes-Rumí L, et al. Among authors: cabrera maqueda jm. Mult Scler Relat Disord. 2020 Sep;44:102311. doi: 10.1016/j.msard.2020.102311. Epub 2020 Jun 20. Mult Scler Relat Disord. 2020. PMID: 32593958
15 results